Novartis Restresses China Commitment As It Outlines 2016 Plans
This article was originally published in PharmAsia News
Executive Summary
Novartis will celebrate the 20th anniversary of the establishment of its independent operations in China this year, and has taken the opportunity to stress its ongoing commitment to this key market in line with its global core strategy, and despite the weaker economic outlook in the country, where it has plans to develop three new key therapeutic areas during 2016.